DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASE
- 1 February 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8426), 415-419
- https://doi.org/10.1016/s0140-6736(85)91144-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.Stroke, 1983
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and PlaceboThrombosis and Haemostasis, 1979
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Resistance to Arteriosclerosis in Pigs with von Willebrand's DiseaseJCI Insight, 1978
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- Platelets and atherosclerosisJournal of Atherosclerosis Research, 1964